Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ran Nussbaum files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Deep Track Biotechnology Master Fund, Ltd. - $20.00M in LBRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ran Nussbaum?
Ran Nussbaum is a corporate insider of LB PHARMACEUTICALS INC (LBRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ran Nussbaum last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2025.
Has Ran Nussbaum been buying or selling stock?
Recorded transactions: 1 open-market purchase ($15.00M) and 0 open-market sales across all tracked filings.